These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2595606)

  • 1. Cholesterol education implications for clinical practice.
    Grundy SM; Bilheimer DW
    Tex Med; 1989 Dec; 85(12):23-7. PubMed ID: 2595606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol. How low should we go?
    Chamsi-Pasha H
    Saudi Med J; 2005 Jan; 26(1):11-8. PubMed ID: 15756346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the risk of coronary heart disease via lipid reduction.
    Spratt KA
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past, present, and future standards for management of dyslipidemia.
    LaRosa JC; Gotto AM
    Am J Med; 2004 Mar; 116 Suppl 6A():3S-8S. PubMed ID: 15050186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Cholesterol Education Program: implications for dietetic practitioners from the Adult Treatment Panel recommendations.
    Ernst ND; Cleeman J; Mullis R; Sooter-Bochenek J; Van Horn L
    J Am Diet Assoc; 1988 Nov; 88(11):1401-8, 1411. PubMed ID: 3183260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Cholesterol Education Program.
    Cleeman JI
    Clin Lab Med; 1989 Mar; 9(1):7-15. PubMed ID: 2647377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.